40 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
and financial position, business strategy, prospective products, product approvals, research and development costs, timing and likelihood of success
PRE 14A
zliva t312xacr
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.2
9u6colpd45seyzrh91
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
424B5
b8dxrm5st1i1c 6vt
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
q46apf4ml 2hknyzfz
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
ftg21 rr8y4baag
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
hulq5y0f3 d6
18 May 20
Prospectus supplement for primary offering
4:11pm